FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) events in patients with coronary artery disease (CAD) and major thrombotic vascular events, such as myocardial infarction, ischemic stroke, acute limb ischemia, and major amputation of a vascular etiology, in patients with PAD, including patients who have recently undergone LER due to symptomatic PAD. CLICK TO TWEET: #BREAKINGNEWS: @US_FDA approves expanded #PeripheralArteryDisease #PAD indication for @JanssenUS treatment, evolving current standard of care for #PAD patients &how long-term prevention of persistent #bloodclot related events are managed. Learn more: bit.ly/33sm1yt“For more than 20 years, many physicians have used dual antiplatelet therapy after lower extremity revascularization due to symptomatic PAD with limited data to support efficacy and safety in this setting. Now, the VOYAGER PAD and COMPASS clinical studies have demonstrated the ...
I have been told the following by my asc. Anyone else ever come across this? “27096 is not reimbursed by Medicare when performed in an ASC. G0260 replaces 27096”
Background Cognitive impairment is prevalent in heart failure and is associated with higher mortality rates. The mechanism behind cognitive impairment in heart failure with preserved ejection fraction (HFpEF) has not been established. Objective The aim of this study was to evaluate associations between abnormal cardiac hemodynamics and cognitive impairment in individuals with HFpEF. Methods A secondary analysis of Atherosclerosis Risk in Communities (Atherosclerosis Risk in Communities) study data was performed. Participants free of stroke or dementia who completed in-person assessments at visit 5 were in...
Papers released by SAGE and subgroup Nervtag warned the highly evolved Omicron super mutant strain could cause a surge in cases 'similar or even larger' than previous waves.
Brazilian President Jair Bolsonaro is facing a potential investigation into comments linking COVID-19 vaccines to AIDS
The White House COVID-19 Response Team announced steps to fortify public health protection before onset of winter and the potential increasing circulation of Omicron.Medscape Medical News
If the finding holds up elsewhere, Omicron may be more difficult to contain than previous iterations of the coronavirus, lengthening the pandemic.
A new mathematical analysis strengthens concerns about the effects of the new variant on the pandemic ’s course.
The arrival of the omicron variant of the coronavirus has health officials in some U.S. communities reviving contact tracing operations in an attempt to slow and understand its spread
This is the FDA ’s first emergency use authorization of a Covid-19 monoclonal antibody treatment in kids as young as newborns.
Officials say a male resident in his 30's from Northwest Philadelphia has tested positive for the omicron variant. #northwestphiladelphia #omicronvariant
More News: African Health | Allergy & Immunology | Anesthesia | Anesthesiology | Antiphospholipid Syndrome | Aspirin | Atrial Fibrillation | Babies | Babies Heart Conditions | Back Pain | Bleeding | Brain | Breastfed | Cancer & Oncology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Child Development | Children | Chronic Pain | Clinical Trials | Clopidogrel | Complementary Medicine | Conferences | Cough | Coumadin | COVID-19 | Dentistry | Diabetes | Diabetes Type 2 | Education | Emergency Medicine | Endocrinology | Epistaxis (Nosebleeds) | Food and Drug Administration (FDA) | Grants | Headache | Health Management | Heart | Heart Attack | Heart Transplant | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Herbs | Hospitals | Hughes Syndrome | Hypertension | Incontinence | Infectious Diseases | Ischemic Stroke | Kidney Transplant | Learning | Legislation | Liver | Liver Transplant | Lung Transplant | Men | Milk | Neurology | Neuroscience | Neurosurgery | Pain | Pain Management | Partnerships | Peripheral Vascular Disease (PVD) | Pharmaceuticals | Plavix | Pregnancy | Profits and Losses | Pulmonary Hypertension | Pulmonary Thromboembolism | Science | Smokers | Sodium | Stroke | Study | Thrombosis | Universities & Medical Training | Urology & Nephrology | Vaccines | Vitamin A | Vitamins | Warfarin | Warnings